REGENXBIO Inc.
RGNX
$7.77
$0.010.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.15M | -61.94M | -70.87M | 6.08M | -51.19M |
| Total Depreciation and Amortization | 3.87M | 3.89M | 3.91M | 3.96M | 4.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 12.47M | 10.09M | 7.18M | 3.88M |
| Change in Net Operating Assets | -1.80M | -10.37M | 7.54M | 16.41M | 11.66M |
| Cash from Operations | -52.29M | -55.96M | -49.34M | 33.63M | -31.62M |
| Capital Expenditure | -508.00K | -491.00K | -391.00K | -1.02M | -1.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.05M | 42.78M | -140.05M | 45.77M | 41.35M |
| Cash from Investing | 37.54M | 42.29M | -140.44M | 44.74M | 40.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.00K | 741.00K | 78.00K | 457.00K | 38.00K |
| Repurchase of Common Stock | 0.00 | -123.00K | 0.00 | -510.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.67M | -7.70M | 139.15M | -5.74M | -7.78M |
| Cash from Financing | -9.58M | -7.08M | 139.23M | -5.79M | -7.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.34M | -20.76M | -50.55M | 72.58M | 909.00K |